{
    "clinical_study": {
        "@rank": "161270", 
        "arm_group": [
            {
                "arm_group_label": "Tibolone", 
                "arm_group_type": "Experimental", 
                "description": "patientes will use tibolone 2,5mg/day during 30 days"
            }, 
            {
                "arm_group_label": "Placebo use", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Patients will use placebo for 30 days"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to evaluate the vascular effects of tibolone on climateric women\n      measured by flow-mediated evaluation of the brachial artery using high resolution ultrasound\n      and compare to placebo."
        }, 
        "brief_title": "Vascular Effect of Tibolone Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Flow-mediated Dilation Evaluation of the Brachial Artery", 
        "condition_browse": {
            "mesh_term": "Dilatation, Pathologic"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Women without menstrual cycles whithin the last 12 months and FSH>30IU/L\n\n          -  Healthy women\n\n          -  Women that were not using drugs with potential vascular effect whithin the last 1\n             year\n\n          -  Women that never used hormone replacement therapy\n\n        Exclusion Criteria:\n\n          -  Smoking\n\n          -  Blood Pressure > 160/90 mm Hg.\n\n          -  Breast and or endometrial cancer\n\n          -  History of acute myocardial infarction\n\n          -  Diabetes\n\n          -  Vaginal bleeding of any origin\n\n          -  Hepatic disease\n\n          -  thrombophlebitis or thromboembolic disorders"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01679795", 
            "org_study_id": "TDILA"
        }, 
        "intervention": [
            {
                "arm_group_label": "Tibolone", 
                "intervention_name": "Tibolone", 
                "intervention_type": "Drug", 
                "other_name": "Livial"
            }, 
            {
                "arm_group_label": "Placebo use", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Tibolone"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "hormone replacement therapy; Dopplervelocimetry; Flow-mediated dilation; menopause; tibolone", 
        "lastchanged_date": "September 5, 2012", 
        "location": {
            "contact": {
                "email": "sjgeber@terra.com.br", 
                "last_name": "selmo geber, MD PhD", 
                "phone": "55 31 34099304"
            }, 
            "contact_backup": {
                "email": "myriancelani@gmail.com", 
                "last_name": "myrian celani, mD", 
                "phone": "55 31 34099664"
            }, 
            "facility": {
                "address": {
                    "city": "belo Horizonte", 
                    "country": "Brazil", 
                    "state": "minas Gerais", 
                    "zip": "30130100"
                }, 
                "name": "hospital das Clinicas - Universidade Federal de Minas Gerais"
            }, 
            "investigator": {
                "last_name": "Selmo Geber, MD PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "sjgeber@terra.com.br", 
            "last_name": "Selmo Geber, MD PhD", 
            "phone": "55 31 34099304"
        }, 
        "overall_contact_backup": {
            "email": "myriancelani@gmail.com", 
            "last_name": "Myrian Celani, MD", 
            "phone": "55 31 34099764"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Brazil: Ethics Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Flow-mediated dilation will be measured by high resolution ultrasound", 
            "measure": "Flow-mediated dilation of the brachial artery one month after treatment started  Flow-mediated dilation of the brachial artery one month after treatment started Flow-mediated dilation of the brachial artery", 
            "safety_issue": "Yes", 
            "time_frame": "30 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01679795"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Federal University of Minas Gerais", 
            "investigator_full_name": "Selmo Geber", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Federal University of Minas Gerais", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Federal University of Minas Gerais", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}